BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• BioMidwest

  INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Dravet Syndrome, A Rare Form Of Epilepsy

  July 2, 2014

   · 

  4 min read
• Policy

  Eagle Pharmaceuticals Receives Tentative Approval For Patented, Ready-to-Dilute Bendamustine Hydrochloride Injection NDA

  July 2, 2014

   · 

  1 min read
• TRANSGENE-Tasly Pharmaceutical JV Reports Immunotherapy Progress

  July 2, 2014

   · 

  1 min read
• Deals

  Colorado’s GlobeImmune, Inc. Prices IPO At $10 A Share, Below Expectations

  July 2, 2014

   · 

  2 min read
• Bio NC

  EpiCypher Announces Epigenetic Grant Program

  July 2, 2014

   · 

  2 min read
• Pharm Country

  NanoViricides, Inc. Reports That Its Director Dr. Milton Boniuk, A Director, Has Invested $5M Into The Company In A Convertible Debenture

  July 2, 2014

   · 

  1 min read
• RBCC Developing New Tech To Help Prevent Deaths From Prescription Overdoses

  July 2, 2014

   · 

  1 min read
• Business

  AIMM Therapeutics’ Partner MedImmune Starts Clinical Studies With RSV Antibody

  July 2, 2014

   · 

  1 min read
• Deals

  Abiomed Announces Acquisition Of ECP To Broaden And Strengthen Existing Intellectual Property And Product Platform

  July 2, 2014

   · 

  1 min read
• Business

  Sectra Has Published Annual Report For Fiscal Year 2013/2014

  July 2, 2014

   · 

  1 min read